Company intelligence

SENS

Senseonics Holdings, Inc. · AMEX · Healthcare

Price$9.38+1.63% · +$0.15

Market cap392.03MEquity value

P / E-4.2Trailing ratio

Volume855.29KLatest session

Market data

SENS price chart

TradingView

Related signals

1 min delayed

Browse public SENS signals with their source context and measured market impact. Open any signal for its permanent analysis page.

SENSMay 1, 2026-0.03% since signal

Senseonics Launch Funding Faces Immediate Stock Pressure

Senseonics Holdings has priced an offering of common stock to raise $80 million for the Eversense 365 launch and pipeline development. However, the dilutive impact has led to a significant sell-off, with shares plummeting over 22% early in trading.

View signal analysis

SENSSep 24, 2024+3.24% since signal

Senseonics Stock Down Despite New FDA Approval for Eversense 365

Senseonics received FDA clearance for Eversense 365, a continuous glucose monitoring system. Eversense 365 offers one year of continuous use, improving diabetes management. The global CGM market is expected to reach $7.51 billion by 2030. SENS shares fell nearly 20% post-announcement despite the positive news. Senseonics reported solid revenue growth and strategic partnerships to enhance market reach.

View signal analysis

Research